How to assess cardiovascular risk in primary care?
Cardiovascular disease remains the leading cause of death globally, and primary care clinicians are on the front lines of prevention. Early and accurate risk assessment allows practitioners to intervene before irreversible damage occurs, tailoring prevention strategies to each patient's individual risk profile.
The 2021 European Society of Cardiology prevention guidelines introduced the SCORE2 risk calculator, and in 2024 the American Heart Association launched the PREVENT risk equation. Both tools represent significant advances over older models by incorporating more risk factors and providing more personalized estimates. Understanding when and how to use these tools is essential for effective primary care practice.
Understanding Cardiovascular Risk Assessment
Cardiovascular risk assessment estimates the probability that an individual without known cardiovascular disease will experience a cardiovascular event within a specific timeframe. The goal is not to diagnose disease but to identify patients who would benefit most from preventive interventions.
Risk calculators translate clinical data into actionable numbers. The SCORE2 calculator estimates 10-year risk of myocardial infarction and stroke for individuals aged 40 to 69. The PREVENT equation goes further, providing both 10-year and 30-year risk estimates for adults aged 30 to 79, and uniquely includes heart failure risk alongside atherosclerotic cardiovascular disease outcomes.
Step-by-Step Risk Assessment Guide
1. Gather traditional risk factors
The foundation of any cardiovascular risk assessment is a thorough collection of patient data.
Required data for risk calculation:
- Age and sex: Both SCORE2 and PREVENT are sex-specific
- Smoking status: Current smoker versus non-smoker
- Systolic blood pressure: Measured in mmHg
- Total cholesterol: Measured in mg/dL or mmol/L
- HDL cholesterol: For both calculators
- Diabetes status: Yes or no
Additional PREVENT-specific factors:
- BMI: Body mass index in kg/m2
- eGFR: Estimated glomerular filtration rate
- Antihypertensive medication use: Current treatment status
- Statin medication use: Whether already on lipid-lowering therapy
These additional variables make PREVENT particularly useful for patients already on preventive medications, as older calculators tended to overestimate risk in treated patients.
2. Choose the appropriate risk calculator
Calculator selection depends on your patient population and clinical question.
Use SCORE2 when:
- Patient is 40 to 69 years old
- You need a 10-year ASCVD risk estimate
- Following European Society of Cardiology guidelines
- Working with European or internationally diverse populations
Use SCORE2-OP for patients over 70:
- Same factors as SCORE2, validated for older populations
Use SCORE2-Diabetes for type 2 diabetes patients:
- Adds HbA1c concentration, age at diabetes diagnosis, and eGFR
Use PREVENT when:
- Patient is 30 to 79 years old
- You want both 10-year and 30-year risk estimates
- The patient is already on statin or antihypertensive therapy
- You want to include heart failure risk assessment
- You prefer race-neutral equations (PREVENT removed the race variable)
The 30-year risk estimate in PREVENT is especially valuable for younger patients, as it supports long-term lifestyle counseling and early intervention.
3. Stratify into risk categories
SCORE2 risk categories (10-year ASCVD risk):
- Low to moderate risk: Below age-specific thresholds
- High risk: 5 percent to under 7.5 percent for patients under 50, 7.5 percent to under 10 percent for patients 50 to 69, 10 percent to under 15 percent for patients over 70
- Very high risk: 7.5 percent or higher for patients under 50, 10 percent or higher for patients 50 to 69, 15 percent or higher for patients over 70
PREVENT risk interpretation:
- Provides absolute risk percentages for 10-year and 30-year periods
- Optimal clinical thresholds are being defined in upcoming ACC/AHA guideline updates
- Studies suggest PREVENT may produce lower risk estimates compared with older Pooled Cohort Equations
4. Consider risk-enhancing factors
Risk calculators have limitations. Certain factors not included in the equations may shift a patient's actual risk higher or lower.
Risk enhancers that may upgrade risk:
- LDL cholesterol 160 to 189 mg/dL
- Triglycerides 175 to 500 mg/dL
- High-sensitivity C-reactive protein above 2 mg/dL
- Lipoprotein(a) above 50 mg/dL
- Apolipoprotein B above 130 mg/dL
- Metabolic syndrome
- History of pre-eclampsia or premature menopause
- Family history of premature vascular disease
- Chronic inflammatory diseases such as rheumatoid arthritis or psoriasis
- Chronic kidney disease
High-risk conditions requiring statin therapy regardless of calculator output:
- Confirmed familial hypercholesterolemia
- LDL cholesterol at or above 190 mg/dL
- Known clinical cardiovascular disease
5. Use coronary artery calcium scoring for uncertain cases
When risk calculator results fall in borderline or intermediate ranges and the decision about statin therapy remains unclear, coronary artery calcium scoring provides direct evidence of subclinical atherosclerosis.
CAC score interpretation:
- CAC equals 0: Below threshold for statin benefit. Consider avoiding or postponing drug therapy, except in patients with diabetes, heavy current smoking, or strong family history of premature cardiovascular disease
- CAC 1 to 99 and below 75th percentile for age, sex, and race: Subclinical atherosclerosis present. Repeat risk discussion. Consider beginning statin or postpone and repeat CAC in 5 years
- CAC at or above 100 or at or above 75th percentile: Above threshold for statin benefit. Recommend statin therapy
CAC scoring is preferable to serum biomarkers for detecting subclinical atherosclerosis, as it is a stronger predictor of cardiovascular events.
6. Apply results to clinical decision-making
For all risk levels:
- Recommend heart-healthy dietary patterns (Mediterranean or plant-based)
- Encourage regular physical activity
- Support smoking cessation
- Address quality sleep
For elevated risk:
- Discuss statin therapy based on risk category and patient preferences
- Consider blood pressure management targets
- Evaluate need for aspirin therapy with caution, as routine aspirin is no longer recommended for primary prevention in most adults
Shared decision-making: Risk estimates should guide conversations, not replace clinical judgment. Discuss the absolute risk number with the patient, explain what it means, and incorporate their preferences, values, and concerns into the treatment plan.
7. Document and track risk over time
Cardiovascular risk is not static. Blood pressure changes, cholesterol levels fluctuate, patients quit or start smoking, and new diagnoses emerge.
Best practices for longitudinal tracking:
- Reassess risk every 4 to 6 years for patients aged 20 to 39 with traditional risk factors
- Reassess more frequently for patients aged 40 to 79 or those with changing risk factors
- Track individual risk factor trends between formal reassessments
- Document the risk calculator used, the date, and the resulting risk category
- Note any risk-enhancing factors present that may influence the assessment
Keeping a structured record of each assessment allows clinicians to identify patterns, evaluate the effectiveness of interventions, and make more informed decisions at each follow-up visit.
Red Flags, When to Refer or Escalate
Refer to cardiology or escalate care when:
- Very high 10-year risk: Especially when combined with multiple risk enhancers
- Familial hypercholesterolemia suspected: LDL at or above 190 mg/dL or family history of premature cardiovascular disease with high cholesterol
- CAC score above 100 or above 75th percentile: Indicates significant subclinical atherosclerosis
- Symptoms suggestive of active cardiovascular disease: Chest pain, dyspnea on exertion, palpitations, or syncope
- Resistant hypertension: Blood pressure uncontrolled despite three or more medications
- Complex diabetes with cardiovascular complications: Requires multidisciplinary management
- Significant valvular abnormalities: Detected on physical examination or imaging
Common Questions
Should I use the same calculator for all patients?
No. Calculator selection depends on patient age, clinical context, and regional guidelines. SCORE2 is recommended for European populations aged 40 to 69, while PREVENT covers a wider age range and includes patients already on preventive medications. For patients with diabetes, use SCORE2-Diabetes. For those over 70, use SCORE2-OP.
What if my patient is already on a statin?
Older calculators like the Pooled Cohort Equations tend to overestimate risk in treated patients. The PREVENT equation accounts for current statin and antihypertensive use, making it more accurate for patients already on preventive therapy.
How often should I reassess cardiovascular risk?
For adults aged 20 to 39 without elevated short-term risk, reassess every 4 to 6 years. For patients aged 40 to 79 or those with changing health status, reassess more frequently. Any significant change in risk factors warrants immediate recalculation.
Is CAC scoring covered by insurance?
Coverage varies. In many systems, CAC scoring is a patient-pay test. However, its ability to reclassify risk and guide statin decisions can make it cost-effective for patients in the borderline or intermediate-risk categories where the treatment decision is uncertain.
Protocol Summary
- Collect traditional risk factors: age, sex, smoking, blood pressure, total cholesterol, HDL cholesterol, diabetes status
- Gather additional PREVENT factors if applicable: BMI, eGFR, medication use
- Select the appropriate risk calculator based on patient age and clinical context
- Calculate 10-year and/or 30-year risk and assign risk category
- Screen for risk-enhancing factors not captured by the calculator
- Consider CAC scoring for borderline or intermediate-risk patients with treatment uncertainty
- Discuss results with the patient using shared decision-making
- Recommend lifestyle interventions for all risk levels
- Initiate or adjust preventive pharmacotherapy based on risk category
- Document the assessment and schedule follow-up for periodic reassessment
How Rovetia Helps
Rovetia converts unstructured patient data such as clinical notes, lab PDFs, voice recordings, and WhatsApp messages into structured, searchable timelines. For cardiology and primary care practices, this means every blood pressure reading, cholesterol panel, and lifestyle counseling session is automatically organized chronologically. Clinicians can track how individual risk factors evolve over time, review past assessments alongside current results, and quickly identify trends that signal the need for intervention. AI-assisted documentation captures the full clinical picture without adding to note-writing burden, while human verification maintains accuracy and auditability.
Sources
- Updates in Cardiovascular Disease Risk Assessment: An International Perspective - American College of Cardiology
- Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease - American Heart Association
- Pocket Guidelines on Cardiovascular Disease Prevention in Clinical Practice - European Society of Cardiology